240 related articles for article (PubMed ID: 17253461)
41. Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers.
van der Heide S; Kauffman HF; Dubois AE; de Monchy JG
Eur Respir J; 1997 Jun; 10(6):1217-23. PubMed ID: 9192919
[TBL] [Abstract][Full Text] [Related]
42. Allergy to house dust mites and asthma.
Milián E; Díaz AM
P R Health Sci J; 2004 Mar; 23(1):47-57. PubMed ID: 15125219
[TBL] [Abstract][Full Text] [Related]
43. Creating a dust-free environment.
Mayo Clin Womens Healthsource; 2004 Apr; 8(4):4-5. PubMed ID: 15088020
[TBL] [Abstract][Full Text] [Related]
44. A review of the effects of impermeable bedding encasements on dust-mite allergen exposure and bronchial hyper-responsiveness in dust-mite-sensitized patients.
Recer GM
Clin Exp Allergy; 2004 Feb; 34(2):268-75. PubMed ID: 14987307
[TBL] [Abstract][Full Text] [Related]
45. Effects of physical interventions on house dust mite allergen levels in carpet, bed, and upholstery dust in low-income, urban homes.
Vojta PJ; Randels SP; Stout J; Muilenberg M; Burge HA; Lynn H; Mitchell H; O'Connor GT; Zeldin DC
Environ Health Perspect; 2001 Aug; 109(8):815-9. PubMed ID: 11564617
[TBL] [Abstract][Full Text] [Related]
46. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
47. [The relationship between the density of house dust mite allergens in bedroom and the attacks of allergic rhinitis].
Xing Z; Li J; Wang M; Wang G; An S; Yu D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Sep; 17(9):547-9. PubMed ID: 14658192
[TBL] [Abstract][Full Text] [Related]
48. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children.
Qureishi A; Burton MJ
Cochrane Database Syst Rev; 2012 Sep; (9):CD004461. PubMed ID: 22972071
[TBL] [Abstract][Full Text] [Related]
49. Topical nasal steroids for intermittent and persistent allergic rhinitis in children.
Al Sayyad JJ; Fedorowicz Z; Alhashimi D; Jamal A
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD003163. PubMed ID: 17253485
[TBL] [Abstract][Full Text] [Related]
50. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis.
Terreehorst I; Duivenvoorden HJ; Tempels-Pavlica Z; Oosting AJ; de Monchy JG; Bruijnzeel-Koomen CA; van Wijk RG
Allergy; 2005 Jul; 60(7):888-93. PubMed ID: 15932378
[TBL] [Abstract][Full Text] [Related]
51. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
52. Comparison of conjunctival and nasal provocation test in allergic rhinitis to house dust mite.
Riechelmann H; Epple B; Gropper G
Int Arch Allergy Immunol; 2003 Jan; 130(1):51-9. PubMed ID: 12576735
[TBL] [Abstract][Full Text] [Related]
53. House dust mite barrier bedding for childhood asthma: randomised placebo controlled trial in primary care [ISRCTN63308372].
Sheikh A; Hurwitz B; Sibbald B; Barnes G; Howe M; Durham S
BMC Fam Pract; 2002 Jun; 3():12. PubMed ID: 12079502
[TBL] [Abstract][Full Text] [Related]
54. Recent advances in house dust allergy: case reports and review.
Listernick JM
N Engl Reg Allergy Proc; 1985; 6(2):153-7. PubMed ID: 3870496
[TBL] [Abstract][Full Text] [Related]
55. Comparison of allergen-induced late inflammatory reactions in the nose and in the skin in house dust mite-allergic patients with or without asthma.
Lopuhaä CE; de Riemer MJ; Out TA; Sjamsoedin DH; Aalberse RC; Jansen HM; van der Zee JS
Int Arch Allergy Immunol; 2003 Apr; 130(4):266-74. PubMed ID: 12740527
[TBL] [Abstract][Full Text] [Related]
56. The biology of dust mites and the remediation of mite allergens in allergic disease.
Arlian LG; Platts-Mills TA
J Allergy Clin Immunol; 2001 Mar; 107(3 Suppl):S406-13. PubMed ID: 11242601
[TBL] [Abstract][Full Text] [Related]
57. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.
Guez S; Vatrinet C; Fadel R; André C
Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522
[TBL] [Abstract][Full Text] [Related]
58. Allergen-avoidance measures in homes of house-dust-mite-allergic asthmatic patients: effects of acaricides and mattress encasings.
van der Heide S; Kauffman HF; Dubois AE; de Monchy JG
Allergy; 1997 Sep; 52(9):921-7. PubMed ID: 9298177
[TBL] [Abstract][Full Text] [Related]
59. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
60. Prevention of sensitization to house dust mite by allergen avoidance in school age children: a randomized controlled study.
Arshad SH; Bojarskas J; Tsitoura S; Matthews S; Mealy B; Dean T; Karmaus W; Frischer T; Kuehr J; Forster J;
Clin Exp Allergy; 2002 Jun; 32(6):843-9. PubMed ID: 12047429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
